Literature DB >> 3120168

Pure red cell hypoplasia secondary to isoniazid.

C R Lewis1, A Manoharan.   

Abstract

We describe a 77 year old man who developed pure red cell aplasia while receiving antituberculous therapy including isoniazid. Prompt recovery occurred following cessation of isoniazid. In this paper we also review previously described case reports of isoniazid-induced pure red cell aplasia.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3120168      PMCID： PMC2428155          DOI： 10.1136/pgmj.63.738.309

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  8 in total

1.  A CASE OF RED CELL APLASIA OCCURRING AS A RESULT OF ANTITUBERCULOUS THERAPY.

Authors:  S B GOODMAN; M H BLOCK
Journal:  Blood       Date:  1964-11       Impact factor: 22.113

2.  Metabolism of C14-isoniazid in humans.

Authors:  R DES PREZ; I U BOONE
Journal:  Am Rev Respir Dis       Date:  1961-07

3.  Phenylbutazone toxicity: depression of erythropoiesis; a case report.

Authors:  O SWINEFORD; J C CURRY; J W CUMBIA
Journal:  Arthritis Rheum       Date:  1958-04

Review 4.  Pure red-cell aplasia.

Authors:  S B Krantz
Journal:  N Engl J Med       Date:  1974-08-15       Impact factor: 91.245

5.  Pure RBC aplasia and diphenylhydantoin.

Authors:  Y G Jeong; Y Jung; G L River
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

6.  Transient erythroid hypoplasia in a patient on long-term co-trimoxazole therapy.

Authors:  M E Stephens
Journal:  Postgrad Med J       Date:  1974-04       Impact factor: 2.401

7.  Pure red blood cell aplasia associated with chlorpropamide therapy. Patient summary and review of the literature.

Authors:  R R Recker; H E Hynes
Journal:  Arch Intern Med       Date:  1969-04

8.  The treatment of pulmonary tuberculosis. Current options.

Authors:  W W Addington
Journal:  Arch Intern Med       Date:  1979-12
  8 in total
  5 in total

1.  Pure red cell aplasia: a rare complication of isoniazid therapy.

Authors:  Ayush Shukla; Sanjay Mishra; Mili Jain; Anil Kumar Tripathi
Journal:  Indian J Hematol Blood Transfus       Date:  2013-01-30       Impact factor: 0.900

2.  Ameliorating role of caffeic acid phenethyl ester (CAPE) against isoniazid-induced oxidative damage in red blood cells.

Authors:  Osman Gokalp; Efkan Uz; Ekrem Cicek; H Ramazan Yilmaz; Mehmet Kaya Ozer; Ayse Altunbas; Nurten Ozcelik
Journal:  Mol Cell Biochem       Date:  2006-09-09       Impact factor: 3.396

3.  Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis.

Authors:  Hideki Nakamura; Akitomo Okada; Atsushi Kawakami; Satoshi Yamasaki; Hiroaki Ida; Masakatsu Motomura; Daisuke Imanishi; Katsumi Eguchi
Journal:  Rheumatol Int       Date:  2009-08-25       Impact factor: 2.631

4.  Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature.

Authors:  Yasuyuki Saito; Yuri Sawada; Yasuhiko Koga; Noriaki Sunaga; Yusuke Tsukagoshi; Yoshimasa Hachisu; Takashi Osaki; Reiko Sakurai; Kyoichi Kaira; Akihiro Ono; Ken Sato; Hiromi Koiso; Tetsunari Oyama; Takeshi Hisada; Masanobu Yamada
Journal:  Intern Med       Date:  2017-09-15       Impact factor: 1.271

5.  Hepatoprotective activity of melittin on isoniazid- and rifampicin-induced liver injuries in male albino rats.

Authors:  Khalid Mohammed Naji; Bushra Yahya Al-Khatib; Nora Saif Al-Haj; Myrene R D'souza
Journal:  BMC Pharmacol Toxicol       Date:  2021-07-03       Impact factor: 2.483
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.